Clinical data, Case examples, and Program development

Protected PCI with #Impella allows for more extensive revascularization in patients with complex coronary artery disease #cardiotwitter pic.twitter.com/PuSRWZ5hEK

From Protected PCI's Twitter

Join us May 1-2 at the Abiomed Heart Recovery Institute in Danvers MA for a course on Building Your Protected PCI Program. Register Now! bit.ly/2Dawimb pic.twitter.com/2Jb6vrTu4n

From Protected PCI's Twitter

Join us on May 19 at the The Cosmopolitan of Las Vegas for a hands-on course, Large Bore Access: Critical Skills for Advanced Interventional Operators at SCAI 2019 Scientific Sessions bit.ly/2Gi1Rv7 #SCAI2019 pic.twitter.com/gTIjhrQkTF

From Protected PCI's Twitter

prev · next

#AbiomedImpella

From the same @CircRes publication: significant survival to discharge benefit with #Impella in patients who did not receive inotropes (56.6% vs. 29.4% p<0.01) bit.ly/2YOZKaN

From Abiomed's Twitter

From the Journal of Interventional Cardiology, 2017: Demonstrates a 48% survival at 30 days when #Impella is implanted pre-PCI, compared to a 13% survival when Impella is implanted post-PCI for left main in #cardiogenicshock (p=0.004) bit.ly/2YPcXjR

From Abiomed's Twitter

From the American Heart Journal: Analysis of 15,259 AMI #cardiogenicshock U.S. patients in the #Impella Quality Database demonstrated an improvement in survival to explant from 52% to 59% when #Impella was placed pre-PCI (p=0.001) bit.ly/2YM2INc

From Abiomed's Twitter

prev · next

National Cardiogenic Shock Initiative: 1 Year Later

Abiomed Cardiogenic Shock Protocol

Cardiogenic Shock Curriculum

Protected PCI

Cardiogenic Shock

Newsletter

Upcoming Events

Limitations of a Recent Matched-Pair Analysis Comparing Impella with IABP

Identifying Cardiogenic Shock Early with a Heart Team Approach

Importance of Right Heart Catheterization

Early Impella Support Associated with Increased Survival in Cardiogenic Shock

Submit Your Case Review

Share File